跳至主要内容
临床试验/ITMCTR2000003783
ITMCTR2000003783尚未招募1 期

A prospective randomized double blind controlled clinical study of Qinggan Jieyu granula in the treatment of primary insomnia

Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 60(—)
性别
Male

入选标准

  • 1. Between 35-65 age, no gender limit;
  • 2. The diagnostic criteria of primary insomina refer to International Classification of sleep disorders (3rd Edition) edited by American Sleep Medicine Association;
  • 3. The diagnostic standard of Fire derived from Stagnation of Liver-QI Type refer to Guidelines for the Clinical Research of Chinese Medicine New Drugs;
  • 4. Volunteer to participate in the research and sign the written informed consent.

排除标准

  • 1. Pregnant and lactating women;
  • 2. Combined with severe heart, liver, lung, kidney and other physical diseases and cancer patients;
  • 3. Sleep disorders caused by nervous system diseases and psychosis;
  • 4. Insomnia caused by drugs or alcohol;
  • 5. alcoholics and drug addicts.

研究者

发起方
Yueyang Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验